SWOT Analysis

What is SWOT Analysis right arrow
Karyopharm Therapeutics Inc
Strengths right arrow 8 S
Weakness right arrow 16 W
Opportunity right arrow 0 O
Threats right arrow 2 T
What is SWOT Analysis ?
Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Significant (over 30%) distance from 52 week high
  • Annual Profit Growth higher than Sector Profit Growth
  • PEG lower than Industry PEG
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year
  • Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
  • Annual Net Profits improving for last 2 years
  • Stock with Low PE (PE < = 10)
  • Highest Recovery from 52 Week Low
  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects
  • Stocks with Quarter Change % less than Industry
  • Promoter holding decreased by more than -2% QoQ
  • Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
  • Lowest Momentum Scores (Technical Scores)
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Highest fall from 52 Week High
  • Top Losers
  • Low Piotroski Score : Companies with weak financials
  • Weak performer : Stock lost more than 20% in 1 month
  • Weak Momentum: Price below Short, Medium and Long Term Averages
  • Declining Revenue every quarter for the past 2 quarters
  • RSI indicating price weakness
  • Top Losers
  • Stocks Underperforming their Industry Price Change in the Quarter
  • Mutual Funds Decreased Shareholding in Past Month
  • MFs decreased their shareholding last quarter
Trendlyne